Status:
COMPLETED
Primary Progesterone Therapy for Operable Breast Cancer
Lead Sponsor:
Tata Memorial Hospital
Collaborating Sponsors:
Ministry of Science and Technology, India
Conditions:
Breast Neoplasms
Eligibility:
FEMALE
18-75 years
Phase:
PHASE2
PHASE3
Brief Summary
The purpose of this study is to test the effect of primary progesterone on overall and disease free survival in women with operable breast cancer. The study addresses two issues related to breast canc...
Detailed Description
This protocol addresses the issue of pre-operative hormone manipulation in women with operable breast cancer. The study has been designed after careful review of literature to assess the effect of uno...
Eligibility Criteria
Inclusion
- Unilateral operable palpable breast cancer
Exclusion
- Previous history of excision biopsy of the primary tumour
- History of other epithelial/mesenchymal malignant tumours except basal cell carcinoma/squamous cell carcinoma (BCC/SCC) of skin
Key Trial Info
Start Date :
October 1 1997
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 29 2020
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT00123669
Start Date
October 1 1997
End Date
May 29 2020
Last Update
July 22 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tata Memorial Hospital
Mumbai, Maharashtra, India, 400012